Alma FemiLift is an FDA-approved laser technology that provides a rapid and highly effective solution for a variety of feminine concerns. Such issues include vaginal dryness, painful intercourse, urinary incontinence and post-partum laxity. The FemiLift yields powerful results with 3 sessions, resulting in more natural lubrication, increased sexual satisfaction, reduced spontaneous urine leakage, and a tighter feeling in the vagina. In addition, women beyond menopause will often have a reduced incident of urinary tract infections.
How FemiLift Works
Fractional CO2 laser technology uses thermal heating to stimulate collagen in the labia majora through the insertion of a slender probe into the vagina. Laser energy is transmitted to the surrounding tissue through a holographic lens that pixelates the beam to 81 microscopic pixels in a 9×9 pattern. The surgical probe features 360 degree rotation that allows the practitioner complete control of the laser, thus providing unrivaled precision in a safe and gentle manner.
How Many Sessions Are Needed?
Most patients will notice positive improvements after their first session. Each treatment lasts under 15 minutes and is performed in the office. Most patients achieve lasting results after 3 sessions. Some women require a rejuvenation boost at 12-18 months.
Is FemiLift Painful?
FemiLift is a virtually painless treatment and there is no downtime following the procedure. Patients can resume daily activity immediately after leaving our office.
What Are The Benefits?
The FemiLift laser treatment stimulates the development of new blood vessels and collagen regeneration in the vaginal area. Patients will enjoy renewed elasticity, increased lubrication and less pain with intimacy, resulting in more sexual satisfaction. In addition, improved bladder control will aid in decreased urine leakage. All of these factors can improve overall well-being and quality of life.
Are There Any Side Effects?
FemiLift is a non-surgical procedure that does not cause skin disruption, scarring or bleeding. The associated risks of the procedure are minimal; women may experience a watery discharge for up to 4 days following treatment.